openPR Logo
Press release

Rheumatoid Arthritis – Diseases & Therapeutic Pipeline Review, H1 2018 Covering Key Vendors 3SBio, 4D Pharma PLC, AB Science SA, AbbVie, Ablynx NV

Rheumatoid Arthritis

Rheumatoid Arthritis

HTF Market Report released a new research document of 1016 pages on industry titled as 'Rheumatoid Arthritis - Pipeline Review, H1 2018' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes important players/vendors such as Adello Biologics LLC, Alteogen , Amarna Therapeutics BV, Amgen, Applied Genetic Technologies etc The report will help you gain market insights, future trends and growth prospects for forecast period.

Request a sample report @ https://www.htfmarketreport.com/sample-report/1226095-rheumatoid-arthritis-pipeline-review-4
Rheumatoid Arthritis - Pipeline Review, H1 2018

HTF’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2018, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.
Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue, and fever and weight loss. Rheumatoid arthritis may be a result of genetic and certain specific environmental factors. Women are much more susceptible to develop RA. Treatment includes non-steroidal anti-inflammatory drugs, corticosteroid medications and immunosuppressants.

Report Highlights
HTF’s Pharmaceutical and Healthcare latest pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 13, 1, 28, 47, 63, 1, 6, 207, 49 and 8 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 4, 32 and 5 molecules, respectively.

Rheumatoid Arthritis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis (Immunology).
- The pipeline guide reviews pipeline therapeutics for Rheumatoid Arthritis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rheumatoid Arthritis (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rheumatoid Arthritis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rheumatoid Arthritis (Immunology)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Rheumatoid Arthritis (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Rheumatoid Arthritis (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1226095

Companies Mentioned in the Report : 3SBio Inc, 4D Pharma PLC, AB Science SA, AbbVie Inc, Ablynx NV, ACEA Biosciences Inc, Aclaris Therapeutics Inc, Adello Biologics LLC, Alteogen Inc, Amarna Therapeutics BV, Amgen Inc, Applied Genetic Technologies Corp, Aptevo Therapeutics Inc, arGentis Pharmaceuticals LLC, Arrien Pharmaceuticals LLC, Arthrogen BV, Asahi Kasei Pharma Corp, Astellas Pharma Inc, AstraZeneca Plc, Atlantic Bio Sci LLC, Aurigene Discovery Technologies Ltd, Axsome Therapeutics Inc, Axxam SpA, Baliopharm AG, Bayer AG, Beijing Hanmi Pharmaceutical Co Ltd, Bio-Cancer Treatment International Ltd, Biocad,Biocon Ltd,Biogen Inc, BioLingus AG, BioLite Inc, Biozeus Pharmaceutical SA,Bird Rock Bio Inc,Boehringer Ingelheim GmbH,Bristol-Myers Squibb Co,BTB Pharma AB,Can-Fite BioPharma Ltd,Cardax Inc,Carna Biosciences Inc,CASI Pharmaceuticals Inc,CEL-SCI Corp,Celgene Corp,Celltrion Inc,Chipscreen Biosciences Ltd,ChironWells GmbH,Chong Kun Dang Pharmaceutical Corp,CJ HealthCare Corp,Clevexel Pharma SAS,Coherus BioSciences Inc,Commence Bio Inc, Compugen Ltd,Crossject SA,CSL Ltd,Cyclacel Pharmaceuticals Inc,Cyxone AB,Daewoong Pharmaceutical Co Ltd,Diamyd Medical AB,Diurnal Group Plc,Domainex Ltd,Dr. Reddy's Laboratories Ltd,Ducentis BioTherapeutics Ltd,Eisai Co Ltd,Enceladus Pharmaceuticals BV,Enzene Biosciences Ltd,F. Hoffmann-La Roche Ltd,Fountain Biopharma Inc,Fresenius SE & Co KGaA,Fujifilm Holdings Corporation,Galapagos NV,Gene Techno Science Co Ltd,Genentech Inc, Genfit SA,Genor BioPharma Co Ltd,Genosco Inc,Gilead Sciences Inc,GlaxoSmithKline Plc,Guangdong Zhongsheng Pharmaceutical Co Ltd,Han Wha Pharma Co Ltd,Hanmi Pharmaceuticals Co Ltd,Hansa Medical AB,Hanwha Chemical Corp,HitGen LTD,Huabo Biopharm Co Ltd,Hualan Biological Engineering Inc,Hutchison MediPharma Ltd,ID Pharma Co Ltd,Idogen AB,Immune Response BioPharma Inc,Immungenetics AG,ImmunoFrontier Inc,ImmunoPrecise Antibodies Ltd,Immunwork Inc,Innate Pharma SA,Innovent Biologics Inc,Intas Pharmaceuticals Ltd,Istesso Ltd,Japan Tobacco Inc,JHL Biotech Inc,Jiangsu Hengrui Medicine Co Ltd,Johnson & Johnson,Jyant Technologies Inc,Kadmon Corp LLC,KAHR medical Ltd,Kang Stem Biotech Co Ltd,KBP BioSciences Co Ltd,Kezar Life Sciences Inc,Lead Pharma Holding BV,LG Chem Ltd,Lipocure Ltd,Livzon Pharmaceutical Group Inc,LSK BioPartners Inc,Lupin Ltd,Mabion SA,mAbxience SA,Maruho Co Ltd,Mebiopharm Co Ltd,MedAnnex Ltd,MedImmune LLC,Merck & Co Inc, Merck KGaA,Mesoblast Ltd,Millennium Pharmaceuticals Inc,Mitsubishi Tanabe Pharma Corp,Momenta Pharmaceuticals Inc,Morphotek Inc,Mycenax Biotech Inc,MYOS RENS Technology Inc,Navigen Inc,Nichi-Iko Pharmaceutical Co Ltd,Nissan Chemical Industries Ltd,Nordic Group BV,Novartis AG,NovelMed Therapeutics Inc,NovImmune SA,Nuevolution AB,Numab Innovation AG,Omeros Corp,Oncodesign SA,OncoImmune Inc,Ono Pharmaceutical Co Ltd,OSE Immunotherapeutics,Paras Biopharmaceuticals Finland Oy,Peptinov SAS,Pfizer Inc,Pharmedartis GmbH,Philogen SpA,PlantForm Corp,PLx Pharma Inc,Principia Biopharma Inc,ProNoxis AB,Protab Ltd,Protalex Inc,Protheragen Inc,Qilu Pharmaceutical Co Ltd,Qu Biologics Inc,R Pharm,ReceptoPharm Inc,RedHill Biopharma Ltd,Reliance Life Sciences Pvt Ltd,Resverlogix Corp,ReveraGen BioPharma Inc,Rhizen Pharmaceuticals SA,Ribomic Inc,Richter Gedeon Nyrt,Rottapharm Biotech Srl,Saje Pharma LLC,Sandoz International GmbH,Sareum Holdings Plc,SBI Biotech Co Ltd,Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd,Shanghai Henlius Biotech Co Ltd,Shanghai Pharmaceutical Co Ltd,Simcere Pharmaceutical Group,Synermore Biologics Co Ltd,Taiho Pharmaceutical Co Ltd,Takeda Pharmaceutical Co Ltd,Teijin Pharma Ltd,TheraMAB LLC,Tiziana Life Sciences Plc,Toleranzia AB,TTY Biopharm Company Ltd,Tumorend LLC,Twoxar Inc,TxCell SA,UCB SA,United BioPharma Inc,Vaccinex Inc,Valeant Pharmaceuticals International Inc,Vicore Pharma AB,X-Rx Inc,Xbrane Biopharma AB,XL-protein GmbH,YiChang Humanwell Pharmaceutical Co Ltd,Yungjin Pharm Co Ltd,Yuyu Pharma Inc,Zhejiang Hisun Pharmaceutical Co Ltd

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1226095-rheumatoid-arthritis-pipeline-review-4

Introduction 10
Rheumatoid Arthritis - Overview 11
Rheumatoid Arthritis - Therapeutics Development 12
Rheumatoid Arthritis - Therapeutics Assessment 60
Rheumatoid Arthritis - Companies Involved in Therapeutics Development 80
Rheumatoid Arthritis - Drug Profiles 167
Rheumatoid Arthritis - Dormant Projects 915
Rheumatoid Arthritis - Discontinued Products 950
Rheumatoid Arthritis - Product Development Milestones 957
Appendix 971List of Tables
Number of Products under Development for Rheumatoid Arthritis, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..4), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..5), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..6), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..7), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..8), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..9), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..10), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..11), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..12), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..13), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Products under Development by Companies, H1 2018 (Contd..4), H1 2018
Products under Development by Companies, H1 2018 (Contd..5), H1 2018
Products under Development by Companies, H1 2018 (Contd..6), H1 2018
Products under Development by Companies, H1 2018 (Contd..7), H1 2018
Products under Development by Companies, H1 2018 (Contd..8), H1 2018
Products under Development by Companies, H1 2018 (Contd..9), H1 2018
Products under Development by Companies, H1 2018 (Contd..10), H1 2018
Products under Development by Companies, H1 2018 (Contd..11), H1 2018
Products under Development by Companies, H1 2018 (Contd..12), H1 2018
Products under Development by Companies, H1 2018 (Contd..13), H1 2018
Products under Development by Companies, H1 2018 (Contd..14), H1 2018
Products under Development by Companies, H1 2018 (Contd..15), H1 2018
Products under Development by Companies, H1 2018 (Contd..16), H1 2018
Products under Development by Companies, H1 2018 (Contd..17), H1 2018
Products under Development by Companies, H1 2018 (Contd..18), H1 2018
Products under Development by Companies, H1 2018 (Contd..19), H1 2018
Products under Development by Companies, H1 2018 (Contd..20), H1 2018
Products under Development by Companies, H1 2018 (Contd..21), H1 2018
Products under Development by Companies, H1 2018 (Contd..22), H1 2018
Products under Development by Companies, H1 2018 (Contd..23), H1 2018
Products under Development by Universities/Institutes, H1 2018
Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..2), H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..3), H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..4), H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..5), H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..6), H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage

....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1226095-rheumatoid-arthritis-pipeline-review-4

It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at
https://www.linkedin.com/company/13388569/
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rheumatoid Arthritis – Diseases & Therapeutic Pipeline Review, H1 2018 Covering Key Vendors 3SBio, 4D Pharma PLC, AB Science SA, AbbVie, Ablynx NV here

News-ID: 1093224 • Views: 772

More Releases from HTF Market Intelligence Consulting Pvt. Ltd.

Airport Service Market Growing Popularity and Emerging Trends | BBA Aviation, Ae …
The latest release from HTF MI highlights the key market trends impacting the growth of the Global Airport Service market. The study highlights influencing factors that are impacting or reinforcing market environment such as Government Policy, technological changes etc along with key market drivers. The research study forecast Revenue Opportunities and Sales Volume Area taken into consideration the primaries from industry experts and includes relevant data such as (revenue, market
Food Garbage Disposer Market Have High Growth But May Foresee Even Higher Value
The latest release from HTF MI highlights the key market trends impacting the growth of the Food Garbage Disposer market. The study highlights influencing factors that are impacting or reinforcing market environment such as Government Policy, technological changes etc along with key market drivers. The research study forecast Revenue Opportunities and Sales Volume Area taken into consideration the primaries from industry experts and includes relevant data such as (revenue, market
Disposable Face Masks- Growing Popularity and Emerging Trends in the Market | 3M …
The latest release from HTF MI highlights the key market trends impacting the growth of the Disposable Face Masks market. The study highlights influencing factors that are impacting or reinforcing market environment such as Government Policy, technological changes etc along with key market drivers. The research study forecast Revenue Opportunities and Sales Volume Area taken into consideration the primaries from industry experts and includes relevant data such as (revenue, market
Credit Repair Services- a Market Worth Observing Growth: Lexington Law, Ovation, …
Global Credit Repair Services Market Outlook provides thoughtful analysis of current issues facing the industry, along with current facts and statistics about the production and application in Global Credit Repair Services Market. The latest research publication released with title Global Credit Repair Services Market by Type (, Type I & Type II), by Application (Private & Enterprise), by Players (Lexington Law, CreditRepair.com, Sky Blue Credit Repair, The Credit People, Ovation,

All 5 Releases


More Releases for Pharm

Global Polygeline Injection Market Forecast 2018-2025 Abbott, Shengtai Pharm, BB …
A detailed market study on "Global Polygeline Injection Market" examines the performance of the Polygeline Injection market. It encloses an in-depth Research of the Polygeline Injection market state and the competitive landscape globally. This report analyzes the potential of Polygeline Injection market in the present and the future prospects from various angles in detail. The Global Polygeline Injection Market 2018 report includes Polygeline Injection market Revenue, market Share, Polygeline Injection industry
Animal Pharm Antibiotics in Animal Production 2016
ReportsWorldwide has announced the addition of a new report title Animal Pharm Antibiotics in Animal Production 2016 to its growing collection of premium market research reports. The global market size for antibiotics use in animal production is large and consumption is projected to reach 105 596 tonnes by 2030. However, extensive evidence now reveals the contribution that antibiotic use has made to the development of antibiotic resistance and its resultant consequences
Animal Pharm: Generics
ReportsWorldwide has announced the addition of a new report title Animal Pharm: Generics to its growing collection of premium market research reports. In 2015, the global animal health market was worth an estimated $30bn. This new thoroughly revised and updated Animal Pharm Generics report focuses primarily on the European and North American markets that comprise around 67% of the global market for animal health products. Also fully reviewed are the EU
Animal Pharm: China Top 20 Companies
ReportsWorldwide has announced the addition of a new report title Animal Pharm: China Top 20 Companies to its growing collection of premium market research reports. The first of its kind published by Informa, the Animal Pharm China Top 20 Companies report explores the sector’s rapid development and reveals how foreign firms are now well-placed to take advantage of opportunities. Home to the world’s largest livestock industry, China has been the object
Animal Pharm Antibiotics in Animal Production 2016
ReportsWorldwide has announced the addition of a new report title Animal Pharm Antibiotics in Animal Production 2016 to its growing collection of premium market research reports. The global market size for antibiotics use in animal production is large and consumption is projected to reach 105 596 tonnes by 2030. However, extensive evidence now reveals the contribution that antibiotic use has made to the development of antibiotic resistance and its resultant consequences
Animal Pharm Antiparisitics
ReportsWorldwide has announced the addition of a new report title Animal Pharm Antiparisitics to its growing collection of premium market research reports. Whether you are already active in the antiparisitics market, or looking to venture in, this report is essential reading to stay ahead of the competition. The antiparasitics sector is a fast growing area of interest to all animal health companies. Animal Parasiticides are used to prevent and treat infestations such as